News
Tirzepatide yielded greater cardiometabolic benefits, especially in total cholesterol, LDL cholesterol, and weight loss, among women than men.
Obesity has become a global epidemic, contributing to a host of chronic health conditions such as type 2 diabetes, hypertension, and cardiovascular disease.
The rise of GLP-1 drugs is a reminder that we must move beyond the equation of thinness as health and value. These drugs are not the answer to the deep-rooted cultural problem of fatphobia ...
Key TakeawaysThe weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer. Tumor ...
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight, food intake and many measures of appetite more than placebo and ...
Weight loss jabs will be given to 3,000 people in a trial to explore whether they can get people back into work, The i Paper understands. A five-year trial of the weight loss drug tirzepatide in ...
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new GLP-1 hits the market.
The jury acquitted Sean "Diddy" Combs of sex trafficking and racketeering, but found him guilty of prostitution offense.
Last year she bought a compounding pharmacy's version of tirzepatide, paying about $470 monthly, and had lost more than 20 pounds when the FDA announced the ban on compounded weight-loss drugs.
Sean “Diddy” Combs’s federal sex-trafficking trial continued Thursday, as closing arguments were heard from the prosecution.
The University of Kansas Medical Center has been awarded a five-year, $31 million grant from the National Institutes of Health to coordinate clinical trials for infants and children in rural and ...
China has booked a rare shipment of soybean meal from Argentina, as the country seeks to secure supplies of a key animal feed ingredient amid an ongoing trade war with the US.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results